| scholarly article | Q13442814 |
| P50 | author | Qiang Gao | Q57089881 |
| Bo-Hao Zheng | Q87990436 | ||
| P2093 | author name string | Jian Zhou | |
| Jia Fan | |||
| Xiao-Ying Wang | |||
| Liu-Xiao Yang | |||
| Jie-Yi Shi | |||
| Qi-Man Sun | |||
| Men Duan | |||
| Hong-Kai Fan | |||
| Zheng-Yao Ma | |||
| P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
| Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience | Q24541622 | ||
| Cancer statistics, 2015 | Q27860576 | ||
| Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men | Q29619308 | ||
| Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States | Q33949931 | ||
| Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? | Q33978005 | ||
| Gallbladder and biliary tract carcinoma: A comprehensive update, Part 1. | Q33979919 | ||
| The role of C-reactive protein as a prognostic indicator in advanced cancer | Q34590826 | ||
| Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine? | Q35048768 | ||
| Quantitative assessment of miR34a as an independent prognostic marker in breast cancer | Q35677744 | ||
| The epidemiology of cholangiocarcinoma | Q35802314 | ||
| Intrahepatic cholangiocarcinoma prognostic determination using pre-operative serum C-reactive protein levels. | Q36161907 | ||
| An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer. | Q36614306 | ||
| Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes | Q36759538 | ||
| Prognostic Value of the Combination of Preoperative Hemoglobin, Lymphocyte, Albumin, and Neutrophil in Patients with Locally Advanced Colorectal Cancer | Q37540276 | ||
| Current surgical management of hilar and intrahepatic cholangiocarcinoma: the role of resection and orthotopic liver transplantation | Q37652249 | ||
| Staging of intrahepatic cholangiocarcinoma. | Q37675065 | ||
| Regulation of the human C-reactive protein gene, a major marker of inflammation and cancer | Q37894871 | ||
| Multidisciplinary approaches to intrahepatic cholangiocarcinoma | Q38130469 | ||
| Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma | Q38200403 | ||
| Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-analysis | Q38203465 | ||
| Activating mutations in PTPN3 promote cholangiocarcinoma cell proliferation and migration and are associated with tumor recurrence in patients | Q39026508 | ||
| C-Reactive protein downregulates TRAIL expression in human peripheral monocytes via an Egr-1-dependent pathway | Q39184142 | ||
| Systematic Review and Meta-Analysis of the Association Between C-Reactive Protein and Major Cardiovascular Events in Patients with Peripheral Artery Disease. | Q39407819 | ||
| Sequential transcatheter arterial chemoembolization and portal vein embolization versus portal vein embolization only before major hepatectomy for patients with hepatocellular carcinoma | Q39818467 | ||
| Surgery of hepatic tumors. | Q40796537 | ||
| Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line | Q40921479 | ||
| Coronary artery disease-associated genetic variants and biomarkers of inflammation | Q40960080 | ||
| A new prognostic scoring system using factors available preoperatively to predict survival after operative resection of perihilar cholangiocarcinoma. | Q41037465 | ||
| Effect of combinations of cytokines and hormones on synthesis of serum amyloid A and C-reactive protein in Hep 3B cells | Q41669884 | ||
| Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience | Q43224624 | ||
| Single determination of C-reactive protein at the time of diagnosis predicts long-term outcome of patients with hepatocellular carcinoma | Q43837250 | ||
| Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer | Q44020050 | ||
| Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy | Q44478933 | ||
| Two-surgeon technique of parenchymal transection contributes to reduced transfusion rate in patients undergoing major hepatectomy: analysis of 1,557 consecutive liver resections | Q45145100 | ||
| Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells | Q46532001 | ||
| Single and multiple cardiovascular biomarkers in subjects without a previous cardiovascular event. | Q47720932 | ||
| The role of C-reactive protein in prostate cancer. | Q50864762 | ||
| Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity. | Q50967175 | ||
| Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma. | Q51711182 | ||
| Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. | Q51766715 | ||
| Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma. | Q53090136 | ||
| Intrahepatic cholangiocarcinoma. | Q53312000 | ||
| Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. | Q53332082 | ||
| The elevated preoperative neutrophil-to-lymphocyte ratio predicts poor prognosis in intrahepatic cholangiocarcinoma patients undergoing hepatectomy. | Q53620039 | ||
| Mutational landscape of intrahepatic cholangiocarcinoma. | Q54300991 | ||
| Inflaming metastasis | Q56942551 | ||
| Serum C-Reactive Protein as Independent Prognostic Variable in Patients with Ovarian Cancer | Q61853683 | ||
| A western surgical experience of peripheral cholangiocarcinoma | Q73027369 | ||
| Preoperative elevation of serum C-reactive protein is related to impaired immunity in patients with colorectal cancer | Q73904827 | ||
| Complement-dependent acute-phase expression of C-reactive protein and serum amyloid P-component | Q73948808 | ||
| X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization | Q80980462 | ||
| What prognostic factors are important for resected intrahepatic cholangiocarcinoma? | Q81294992 | ||
| Preoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinoma | Q81665959 | ||
| P433 | issue | 10 | |
| P921 | main subject | cholangiocarcinoma | Q124292 |
| P304 | page(s) | e118 | |
| P577 | publication date | 2017-10-05 | |
| P1433 | published in | Clinical and translational gastroenterology | Q27723002 |
| P1476 | title | A New Preoperative Prognostic System Combining CRP and CA199 For Patients with Intrahepatic Cholangiocarcinoma | |
| P478 | volume | 8 |
| Q89457793 | CD86+/CD206+ tumor-associated macrophages predict prognosis of patients with intrahepatic cholangiocarcinoma |
| Q92242902 | Clinical Significance of Prothrombin Time in Cholangiocarcinoma Patients with Surgeries |
| Q96135374 | Drug-eluting beads transarterial chemoembolization with CalliSpheres microspheres for treatment of unresectable intrahepatic cholangiocarcinoma |
| Q91841971 | Long-term outcome and prognostic factors of combined hepatocellular carcinoma and cholangiocarcinoma after curative resection |
| Q64262951 | Predicting peritumoral Glisson’s sheath invasion of intrahepatic cholangiocarcinoma with preoperative CT imaging |
| Q59336080 | Radiomics score: a potential prognostic imaging feature for postoperative survival of solitary HCC patients |
| Q92714655 | Role of CA19-9 in the prognostic evaluation of SOX neoadjuvant chemotherapy for gastric cancer |
| Q96166991 | The distribution of immune cells within combined hepatocellular carcinoma and cholangiocarcinoma predicts clinical outcome |
Search more.